The new US legislation will forever alter the commercial landscape for biologics.
Jonathan Harris
Advertisement
Jonathan Harris is a partner at Axinn, Veltrop & Harkrider LLP
Articles by Jonathan Harris
Advertisement
Latest Updated Articles
Five Things Every Biotech Company Must Know About BiosimilarsPublished: June 1st 2010 | Updated:
Advertisement
Advertisement
